Stockscreener 앱 받기
1.7652
4.14%
0.0752
전일 마감가:
$1.69
열려 있는:
$1.7
하루 거래량:
72,756
Relative Volume:
0.29
시가총액:
$10.14M
수익:
-
순이익/손실:
$-26.23M
주가수익비율:
-1.4382
EPS:
-1.2274
순현금흐름:
$-10.29M
1주 성능:
+12.10%
1개월 성능:
-12.00%
6개월 성능:
-78.92%
1년 성능:
-91.37%
1일 변동 폭
$1.6886
$1.7899
1주일 범위
$1.50
$1.7899
52주 변동 폭
$1.50
$42.92
Seastar Medical Holding Corp Stock (ICU) Company Profile
명칭
Seastar Medical Holding Corp
전화
844-427-8100
주소
3513 BRIGHTON BLVD, DENVER
ICU을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ICU
Seastar Medical Holding Corp
|
1.76 | 10.14M | 0 | -26.23M | -10.29M | -1.2274 |
|
VRTX
Vertex Pharmaceuticals Inc
|
440.94 | 113.70B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
682.32 | 75.52B | 13.85B | 4.65B | 3.32B | 40.41 |
|
ARGX
Argen X Se Adr
|
663.74 | 39.78B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
275.41 | 35.34B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
121.31 | 29.05B | 3.30B | -501.07M | 1.03B | -2.1146 |
Seastar Medical Holding Corp 주식(ICU)의 최신 뉴스
SeaStar Medical Adds Fifth Hospital Customer for QUELIMMUNE - GlobeNewswire
ICU News Today | Why did SeaStar Medical stock go up today? - MarketBeat
SeaStar Shares Static Ahead of Drug Trials - Baystreet.ca
SeaStar Medical Activates 15th Site for its Adult Acute Kidney Injury Pivotal Trial - GlobeNewswire
SeaStar Medical says FDA approves feasibility study with SCD-ADULT - Yahoo Finance
SeaStar Medical Gains FDA Approval for Pediatric Device - TipRanks
FDA Approves Feasibility Study with SeaStar Medical’s - GlobeNewswire
SeaStar Medical Secures FDA Approval for Breakthrough Heart Failure Treatment Study - StockTitan
SeaStar Medical Begins Shipping QUELIMMUNE to a Fourth Hospital Customer - GlobeNewswire
Seastar Medical Begins Shipping Quelimmune to A Fourth Hospital Customer - Marketscreener.com
AtriCure (NASDAQ:ATRC) versus SeaStar Medical (NASDAQ:ICU) Critical Contrast - Defense World
Financial Review: Globus Medical (NYSE:GMED) vs. SeaStar Medical (NASDAQ:ICU) - Defense World
ICUSeaStar Medical Holding Corporation Latest Stock News & Market Updates - StockTitan
SeaStar Medical Activates 14th Hospital for its Adult AKI Pivotal Trial - GlobeNewswire
SeaStar Medical Activates 14th Hospital for its Adult AKI Pivotal Trial - GlobeNewswire Inc.
Analyzing SeaStar Medical (NASDAQ:ICU) & Aethlon Medical (NASDAQ:AEMD) - Defense World
SEASTAR ALERT: Bragar Eagel & Squire, P.C. is Investigating - GlobeNewswire
ICU stock hits 52-week low at $1.82 amid market challenges - Investing.com
Medical Device Co. Brass Hid SPAC's True Value, Suit Says - Law360
SeaStar Medical Projects Multibillion-Dollar Market - GlobeNewswire
SeaStar Medical to Hold Business Update Conference Call on December 11, 2024 - GlobeNewswire
SeaStar Medical Activates Sentara Norfolk General Hospital and Provides Enrollment Update in Adult AKI Pivotal Trial - GlobeNewswire
SeaStar Medical Provides Updates on Enrollment of Adult Pivotal Clinical Study and Commercial Launch of Quelimmune - Investing.com Nigeria
SeaStar Medical (NASDAQ:ICU) Trading Down 1.6% – What’s Next? - Defense World
SeaStar Medical reduces authorized shares By Investing.com - Investing.com Canada
SeaStar Medical reduces authorized shares - Investing.com
SeaStar Medical to Present at Noble Capital Markets’ NobleCon20 on December 4, 2024 - GlobeNewswire
SeaStar Medical to Present at NobleCon20 Conference on Hyperinflammation Solutions | ICU Stock News - StockTitan
Leading Independent Proxy Advisory Firms ISS and Glass - GlobeNewswire
Leading Independent Proxy Advisory Firms ISS and Glass Lewis Support SeaStar Medical's Proposals to Ratify the Issuance of Shares and to Reduce the Number of Authorized Shares - Quantisnow
SeaStar Medical chief medical officer purchases $8,457 in stock By Investing.com - Investing.com Australia
SeaStar Medical chief medical officer purchases $8,457 in stock - Investing.com
Seastar Soars On Latest Tidings - MENAFN.COM
SeaStar Soars on Latest Tidings - Baystreet.ca
SeaStar Medical Reaches Milestone of 100th QUELIMMUNE Commercial Device as Shipments Begin to its Third Hospital Customer - Yahoo Finance
SeaStar Medical reports net revenue of USD 67,500 in Q3 2024 - Medical Buyer
SeaStar Medical Reports Third Quarter 2024 Financial Results and Provides a Business Update - Yahoo Finance
Half of Patients Now Enrolled in SeaStar Medical’s NEUTRALIZE-AKI Trial - MPO-mag
Critical Analysis: Merit Medical Systems (NASDAQ:MMSI) and SeaStar Medical (NASDAQ:ICU) - Defense World
SeaStar Medical (NASDAQ:ICU) Trading Down 3% – Here’s What Happened - Defense World
FDA grants breakthrough status to SeaStar Medical's SCD - Investing.com
FDA Grants Breakthrough Device Designation for SeaStar - GlobeNewswire
FDA Grants Breakthrough Device Designation for SeaStar Medical’s Selective Cytopheretic Device for Adults Undergoing Chronic Dialysis - Yahoo Finance
Record Monthly Enrollment Achieved in SeaStar Medical’s Pivotal Adult AKI Trial - GlobeNewswire
SeaStar Medical Adds Second Hospital Customer for QUELIMMUNE - Yahoo Finance
Economic Analysis Supporting Significant Hospitalization Cost Reduction with SeaStar Medical’s QUELIMMUNE Pediatric Therapeutic Device Presented at ASN Kidney Week 2024Update - Yahoo Finance
Seastar Medical Holding Corp (ICU) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Seastar Medical Holding Corp 주식 (ICU) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Chung Kevin | Chief Medical Officer |
Sep 30 '24 |
Buy |
4.26 |
1,000 |
4,258 |
9,435 |
0.45%
4.93%
자본화:
|
볼륨(24시간):